Infectious Agents and Cancer

Papers
(The TQCC of Infectious Agents and Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses52
Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population36
HPV prevalence and genotype distribution among women in Sanming, China: a retrospective analysis before large-scale vaccination35
HPV16/HPV58 viral load is non-linearly correlated with cervical lesions and can be used as a triage marker35
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status32
Inhibitory effect and mechanism of Lactobacillus crispatus on cervical precancerous cells Ect1/E6E7 and screening of early warning factors30
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation28
The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review28
Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?27
Analysis of the triage value of multigene methylation testing for CIN2 + in hrHPV-positive patients24
Mendelian randomization in cancer research: opportunities and challenges23
Correction: A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China23
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma21
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis21
Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors20
Precision therapeutic targets for HPV-positive cancers: an overview and new insights20
Skin biopsy processing for rapid molecular diagnosis and histopathologic interpretation: application to Kaposi sarcoma in East Africa20
Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 19
The effectiveness of a model-based health education program on genital warts preventive behaviors: a quasi-experimental study19
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer18
Cox proportional hazard-model application: time to cervical cancer screening among women living with HIV in South Africa17
Highly sensitive deep panel sequencing of 27 HPV genotypes in prostate cancer biopsies results in very low detection rates and indicates that HPV is not a major etiological driver of this malignancy16
Development and validation of a multiplex qPCR method for identification of high-risk genotypes of human papillomavirus15
Correction: Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases15
Prevalence of HPV in anal cancer: exploring the role of infection and inflammation14
Clinical characteristics and prognostic impact of HPV infection in head and neck cancer patients in China: a nationwide multicenter study14
Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes14
CTSG may inhibit disease progression in HIV-related lung cancer patients by affecting immunosuppression14
Chlamydia pneumoniae infections and development of lung cancer: systematic review14
Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis14
The viral origins of breast cancer13
Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics13
An overview of mouse models of hepatocellular carcinoma12
Mandatory preventive vaccines for infectious diseases expressing T-cell epitopes for cancer prevention12
Multiple pathogens and prostate cancer12
Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series12
Polygenic risk scores for cervical HPV infection, neoplasia and cancer show potential for personalised screening: comparison of two methods12
The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period12
Low frequency of HPV positivity in breast tumors among patients from south-central Poland11
A comparative analysis of somatic mutational profiles according to HIV status among women with cervical intraepithelial neoplasia 3 (CIN3): a focus on hotspots in TP53, PIK3CA, PTEN, and EGFR11
Primary seminal vesicle Burkitt lymphoma in a patient living with HIV undergoing radical prostate and seminal vesicle resection: a rare missed case report11
Assessing the risk of high-grade squamous intraepithelial lesions (HSIL+) in women with LSIL biopsies: a machine learning-based study11
A SEER-based analysis of trends in HPV-associated oropharyngeal squamous cell carcinoma10
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial10
Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran10
Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer10
Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study10
Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006–20179
Undifferentiated carcinoma of the liver with osteoclast-like giant cells: a case report and literature review9
Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection9
Investigating the expression of HERV-K env, np9, gag, and rec in bladder cancers9
Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women9
Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation9
Detection of bovine leukemia virus, Epstein-Barr virus and human papillomavirus in breast cancer tissues of Egyptian patients9
Correction: HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study9
Correction: Utilization of cervical cancer screening services and its associated factors in Iran: a case–control study9
Molecular triage of cervical screening samples in women 55–59 years of age: a pilot study8
Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: resu8
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-38
Microbiota and metabolite profiles of saliva, oral swab and cancer tissue from patients with oral squamous cell carcinoma (OSCC)8
Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma7
Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study7
High-risk human papillomavirus genotyping in cervical cancers in Tanzania7
Seroprevalence of human papilloma virus 6, 11, 16 and 18 among pregnant women in Mwanza-Tanzania7
Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites7
Incidence of de novo HPV infections in a previous HPV-negative group, related to use of different contraceptive methods: a retrospective cohort study7
Impact of Epstein-Barr virus and CD lymphocytes on the prognosis of patients with advanced nasopharyngeal carcinoma6
Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection6
Distribution patterns of human papillomavirus genotypes among women in Guangzhou, China6
Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequenc6
High-risk HPV genotypes in women with abnormal cytology: a 12-year retrospective study6
Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic6
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation6
An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infecti6
Tumor-infiltrating CD4+ CD25+ FOXP3+ Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma6
CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance6
High-risk human papillomavirus genotype distribution among women with gynecology complaints in northwest Ethiopia6
Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly6
0.046497106552124